×

Ariad cancer drug pricing under congressional scrutiny

1:07 PM ET Thu, 20 Oct 2016

CNBC's Meg Tirrell reports the latest on a tweet sent by Sen. Bernie Sanders about Ariad Pharmaceuticals' cancer drug pricing.